tiprankstipranks
Immucell Corp. (ICCC)
NASDAQ:ICCC

Immucell (ICCC) Financial Statements

69 Followers

Immucell Financial Overview

Immucell's market cap is currently ―. The company's EPS TTM is $-0.503; its P/E ratio is -8.49; Immucell is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 5.10M$ 5.40M$ 3.53M$ 3.45M$ 3.91M
Gross Profit$ 1.26M$ 1.27M$ 1.04M$ 300.77K$ 992.18K
EBIT$ -975.46K$ -795.15K$ -1.29M$ -2.40M$ -2.19M
EBITDA$ -290.48K$ -86.06K$ -600.98K$ -1.75M$ -3.43M
Net Income Common Stockholders$ -1.14M$ -940.00K$ -1.38M$ 9.21M$ -1.89M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 978.74K$ 1.99M$ 1.45M$ 3.10M$ 5.79M
Total Assets$ 43.81M$ 44.55M$ 44.01M$ 43.12M$ 44.86M
Total Debt$ 16.69M$ 16.68M$ 15.10M$ 13.22M$ 12.48M
Net Debt$ 15.71M$ 14.69M$ 13.65M$ 10.13M$ 6.69M
Total Liabilities$ 18.82M$ 18.53M$ 17.15M$ 14.96M$ 14.48M
Stockholders Equity$ 24.99M$ 26.01M$ 26.86M$ 28.16M$ 30.38M
Cash Flow-
Free Cash Flow$ -689.29K$ -1.04M$ -1.39M$ -3.44M$ -2.79M
Operating Cash Flow$ -723.07K$ -507.75K$ -681.43K$ -2.76M$ -1.30M
Investing Cash Flow$ 33.78K$ -533.26K$ -708.41K$ -682.15K$ -1.49M
Financing Cash Flow$ -321.43K$ 1.58M$ -251.90K$ 748.62K$ -248.21K
Currency in USD

Immucell Earnings and Revenue History

Immucell Debt to Assets

Immucell Cash Flow

Immucell Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis